Literature DB >> 19754100

Alotamide A, a novel neuropharmacological agent from the marine cyanobacterium Lyngbya bouillonii.

Irma E Soria-Mercado1, Alban Pereira, Zhengyu Cao, Thomas F Murray, William H Gerwick.   

Abstract

Alotamide A (1), a structurally intriguing cyclic depsipeptide, was isolated from the marine mat-forming cyanobacterium Lyngbya bouillonii collected in Papua New Guinea. It features three contiguous peptidic residues and an unsaturated heptaketide with oxidations and methylations unlike those found in any other marine cyanobacterial metabolite. Pure alotamide A (1) displays an unusual calcium influx activation profile in murine cerebrocortical neurons with an EC50 of 4.18 microM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19754100      PMCID: PMC2759415          DOI: 10.1021/ol901438b

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  18 in total

1.  New apratoxins of marine cyanobacterial origin from Guam and Palau.

Authors:  Hendrik Luesch; Wesley Y Yoshida; Richard E Moore; Valerie J Paul
Journal:  Bioorg Med Chem       Date:  2002-06       Impact factor: 3.641

Review 2.  Excitotoxic cell death.

Authors:  D W Choi
Journal:  J Neurobiol       Date:  1992-11

Review 3.  Biogenetic diversity of cyanobacterial metabolites.

Authors:  Ryan M Van Wagoner; Allison K Drummond; Jeffrey L C Wright
Journal:  Adv Appl Microbiol       Date:  2007       Impact factor: 5.086

4.  Brevetoxin-induced autocrine excitotoxicity is associated with manifold routes of Ca2+ influx.

Authors:  F W Berman; T F Murray
Journal:  J Neurochem       Date:  2000-04       Impact factor: 5.372

5.  Influence of the distance of the proline carbonyl from the beta and gamma carbon on the 13C chemical shifts.

Authors:  I Z Siemion; T Wieland; K H Pook
Journal:  Angew Chem Int Ed Engl       Date:  1975-10       Impact factor: 15.336

6.  cis,cis- and trans,trans-ceratospongamide, new bioactive cyclic heptapeptides from the Indonesian red alga Ceratodictyon spongiosum and symbiotic sponge Sigmadocia symbiotica.

Authors:  L T Tan; R T Williamson; W H Gerwick; K S Watts; K McGough; R Jacobs
Journal:  J Org Chem       Date:  2000-01-28       Impact factor: 4.354

7.  Hoiamide a, a sodium channel activator of unusual architecture from a consortium of two papua new Guinea cyanobacteria.

Authors:  Alban Pereira; Zhengyu Cao; Thomas F Murray; William H Gerwick
Journal:  Chem Biol       Date:  2009-08-28

8.  Crystal structure of the ECH2 catalytic domain of CurF from Lyngbya majuscula. Insights into a decarboxylase involved in polyketide chain beta-branching.

Authors:  Todd W Geders; Liangcai Gu; Jonathan C Mowers; Haichuan Liu; William H Gerwick; Kristina Håkansson; David H Sherman; Janet L Smith
Journal:  J Biol Chem       Date:  2007-10-10       Impact factor: 5.157

9.  Cloning and biochemical characterization of the hectochlorin biosynthetic gene cluster from the marine cyanobacterium Lyngbya majuscula.

Authors:  Aishwarya V Ramaswamy; Carla M Sorrels; William H Gerwick
Journal:  J Nat Prod       Date:  2007-11-15       Impact factor: 4.050

10.  Lyngbouilloside, a novel glycosidic macrolide from the marine cyanobacterium Lyngbya bouillonii.

Authors:  Lik Tong Tan; Brian L Márquez; William H Gerwick
Journal:  J Nat Prod       Date:  2002-06       Impact factor: 4.050

View more
  15 in total

Review 1.  Biological targets and mechanisms of action of natural products from marine cyanobacteria.

Authors:  Lilibeth A Salvador-Reyes; Hendrik Luesch
Journal:  Nat Prod Rep       Date:  2015-03       Impact factor: 13.423

Review 2.  Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology.

Authors:  Vedanjali Gogineni; Mark T Hamann
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-24       Impact factor: 3.770

3.  Palmyrolide A, an unusually stabilized neuroactive macrolide from Palmyra Atoll cyanobacteria.

Authors:  Alban R Pereira; Zhengyu Cao; Niclas Engene; Irma E Soria-Mercado; Thomas F Murray; William H Gerwick
Journal:  Org Lett       Date:  2010-10-15       Impact factor: 6.005

Review 4.  New peptides isolated from Lyngbya species: a review.

Authors:  Li Liu; Kathleen S Rein
Journal:  Mar Drugs       Date:  2010-06-09       Impact factor: 5.118

5.  Tetramethylenedisulfotetramine alters Ca²⁺ dynamics in cultured hippocampal neurons: mitigation by NMDA receptor blockade and GABA(A) receptor-positive modulation.

Authors:  Zhengyu Cao; Bruce D Hammock; Mark McCoy; Michael A Rogawski; Pamela J Lein; Isaac N Pessah
Journal:  Toxicol Sci       Date:  2012-08-13       Impact factor: 4.849

Review 6.  Marine pharmacology in 2009-2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2013-07-16       Impact factor: 5.118

7.  Prediction aided in vitro analysis of octa-decanoic acid from Cyanobacterium Lyngbya sp. as a proapoptotic factor in eliciting anti-inflammatory properties.

Authors:  Paramasivan Manivannan; Gangatharan Muralitharan; Nainangu Prasanna Balaji
Journal:  Bioinformation       Date:  2017-09-30

Review 8.  New Peptides Isolated from Marine Cyanobacteria, an Overview over the Past Decade.

Authors:  Yue Mi; Jinrong Zhang; Shan He; Xiaojun Yan
Journal:  Mar Drugs       Date:  2017-05-05       Impact factor: 5.118

Review 9.  Marine cyanobacteria compounds with anticancer properties: a review on the implication of apoptosis.

Authors:  Margarida Costa; João Costa-Rodrigues; Maria Helena Fernandes; Piedade Barros; Vitor Vasconcelos; Rosário Martins
Journal:  Mar Drugs       Date:  2012-09-28       Impact factor: 6.085

10.  Bouillonamide: a mixed polyketide-peptide cytotoxin from the marine cyanobacterium Moorea bouillonii.

Authors:  Lik Tong Tan; Tatsufumi Okino; William H Gerwick
Journal:  Mar Drugs       Date:  2013-08-19       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.